iCELLis500: A versatile Manufacturing Platform for CGT and Oncolytic Virus Production

The poster showcases two pivotal Phase III client projects: an AAV-based therapy and an innovative oncolytic virus (Parvovirus) approach – both leveraging the cutting-edge iCELLis500+ platform.